Testing Protocol to Efficiently Induce Itch
Launched by AALBORG UNIVERSITY · Jan 13, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy men and women in the age 18-80 years who speak and understand
- Exclusion Criteria:
- • Pregnancy or breast feeding
- • Drug addiction defined as the use of cannabis, opioids or other drugs
- • Previous and present neurologic, musculoskeletal or mental illnesses (e.g., epilepsy, neuropathy, fibromyalgia and depression)
- • Skin diseases
- • Past history of conditions possibly leading to neuropathy
- • Inability to cooperate
- • Current use of medications that may affect the study, e.g., analgesics
- • Previous traumatic experience of an electrical accident
- • Consumption of alcohol or painkillers within the last 24 hours
- • Participation in other pain studies throughout the study period
- • Patients with cardiac diseases (e.g., pacemaker).
About Aalborg University
Aalborg University is a leading research institution based in Denmark, renowned for its innovative approach to education and research in engineering, natural sciences, and health sciences. With a commitment to advancing knowledge and improving public health outcomes, Aalborg University actively engages in clinical trials that explore cutting-edge medical solutions and interventions. The university fosters interdisciplinary collaboration, leveraging its expertise to enhance clinical research methodologies and contribute to the development of evidence-based practices in healthcare. Through its rigorous scientific inquiry and dedication to ethical standards, Aalborg University plays a pivotal role in shaping the future of health research and improving patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aalborg, , Denmark
Aalborg, Nordjylland, Denmark
Aalborg, Aalborg ø, Denmark
Patients applied
Trial Officials
Jenny Tigerholm
Principal Investigator
Aalborg University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials